tislelizumab
beigene,novartis
['nsclc', 'sclc', 'tislelizumab', 'lcsm,(-blcsm)']
tislelizumab provides favorable efficacy in asian and non-asian patients with previously treated advanced nsclc #esmo2022 #lcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.